# vGRID SBRT: A Phase I Clinical Trial in Unresectable or Metastatic HCC

> **NCT05727787** · NA · RECRUITING · sponsor: **University of Kansas Medical Center** · enrollment: 18 (estimated)

## Conditions studied

- Liver Cancer

## Interventions

- **RADIATION:** Stereotactic Body Radiation Treatment

## Key facts

- **NCT ID:** NCT05727787
- **Lead sponsor:** University of Kansas Medical Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-02-23
- **Primary completion:** 2026-08-31
- **Final completion:** 2028-08-31
- **Target enrollment:** 18 (ESTIMATED)
- **Last updated:** 2025-12-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05727787

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05727787, "vGRID SBRT: A Phase I Clinical Trial in Unresectable or Metastatic HCC". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05727787. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*